NPM1 and acute myeloid leukemia: Frameshift mutations of nucleophosmin 1 (NPM1) are one of the most frequent molecular abnormalities in AML that remain relatively stable in the course of the disease and therefore represent an ideal target for RT-qPCR MRD monitoring [7, 8].